The Revel Collective Plc (AIM:TRC)
London · Delayed Price · Currency is GBP · Price in GBX 0.2750
0.00 (0.00%)
At close: Oct 22, 2025
The Revel Collective Employees
The Revel Collective had 3,094 employees as of June 29, 2024. The number of employees decreased by 406 or -11.60% compared to the previous year.
Employees
3,094
Change (1Y)
-406
Growth (1Y)
-11.60%
Revenue / Employee
42.48K GBP
Profits / Employee
-3.14K GBP
Market Cap
4.13M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 29, 2024 | 3,094 | -406 | -11.60% |
| Jul 1, 2023 | 3,500 | 673 | 23.81% |
| Jul 2, 2022 | 2,827 | 332 | 13.31% |
| Jul 3, 2021 | 2,495 | -405 | -13.97% |
| Jun 27, 2020 | 2,900 | -400 | -12.12% |
| Jun 29, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 1, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 2, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 27, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| HSBC Holdings | 211,304 |
| Unilever | 115,964 |
| BP p.l.c. | 100,500 |
| Shell | 96,000 |
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Rio Tinto Group | 60,000 |
| British American Tobacco p.l.c. | 48,989 |
The Revel Collective News
- 21 hours ago - Trinity Capital Inc. Provides Equipment Financing to Bobbie, Bolstering Domestic Infant Formula Industry - PRNewsWire
- 2 days ago - Yield Hunting Part 35: Trinity Capital's Baby Bonds At 7% Yield To Worst - Seeking Alpha
- 2 days ago - Dividend Power Dogs: 13 Ideal Safer October Stars - Seeking Alpha
- 2 days ago - Trinity Capital Inc. Provides $15 Million in Growth Capital to Kard, Accelerating Growth of Its Commerce Media Network - PRNewsWire
- 4 days ago - Fearful About BDCs? Be Greedy - Seeking Alpha
- 5 days ago - Power The American Dream And Collect 8% Yields - Seeking Alpha
- 5 days ago - The Big BDC Meltdown Of 2025 Is Underway - Seeking Alpha
- 9 days ago - Trinity Capital Inc. Provides $130 Million in Growth Capital to Candel Therapeutics, Supporting Development of Viral Immunotherapies to Fight Cancer - PRNewsWire